Clinical Trials

Drug Detoxification Clinical Research

Since 2012, SceneRay cooperated with Professor Gao Guodong of Air Force Military Medical University to develop a drug-reducing brain-computer chip and a drug-reducing DBS system based on theoretical and technological innovations in addiction mechanisms, committed to solving the high relapse after drug addiction. Rate this worldwide problem. A single-center detoxification clinical trial has been completed and breakthrough results have been achieved. This result has been published in Brain Stimulation, an international authoritative magazine. In addition, this product was approved by the "Innovative Green Channel" of China Food and Drug Administration in 2017. This detoxification brain pacemaker is the world's first medical device with multi-targets combined regulation in the brain for drug addiction and treatment of mental illness. This research is a global leader in this field.

Previous clinical trials suggest that SceneRay’s drug detoxification DBS system can effectively reduce the psychological craving of drug addicts, thereby greatly reducing the relapse rate, and is expected to achieve a true drug addiction withdrawal. At present, SceneRay detoxification DBS system is undergoing strict national standard (prospective, multi-center, double-blind, randomized controlled) national multi-center clinical trials, which has further verified its therapy. Participants include: Tangdu Hospital affiliated to Air Force Military Medical University, Peking University Chinese Drug Dependence Research Institute, Ruijin Hospital affiliated to Shanghai Jiaotong University, West China Hospital affiliated to Sichuan University, and Southern Hospital affiliated to Southern Medical University. Subjects are being recruited.

SceneRay detoxification DBS system is expected to provide a new technology and model for solving the world problem of drug addiction treatment.